Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostra Terra Regulatory News (NTOG)

  • There is currently no data for NTOG

Oversubscribed Fundraise

25 Sep 2020 12:10

RNS Number : 1692A
Nostra Terra Oil & Gas Company PLC
25 September 2020
 

25 September 2020

 

Nostra Terra Oil and Gas Company plc

("Nostra Terra" or the "Company")

 

Oversubscribed Fundraise

 

Nostra Terra (AIM: NTOG), the oil & gas exploration and production company with a portfolio of development and production assets in Texas, USA, is pleased to announce completion of an oversubscribed fundraise of ÂŁ500,000 with institutional and professional investors.

During the current quarter, Nostra Terra acquired the Caballos Creek Asset - an oil producing asset in South Texas, progressed drilling plans for a new well at Pine Mills and signed a farm-in agreement for a new oil producing asset in the Permian Basin.

The net proceeds of the fundraise will be used on the new Permian Basin farm-in asset, the upcoming well at Pine Mills, and for general working capital purposes, including evaluation of other potential acquisitions or development of assets such as Caballos Creek. Work is focused on assets that will generate near-term cashflow with lasting reserves. 

Nostra Terra's current work programme is now funded and the activity is anticipated to produce significant additional cashflow for the Company and remain robust, even at subdued oil prices.

The Company intends to provide a further update on all areas of operation in the near future.

Fundraise

The Company has raised, in aggregate, £500,000, before expenses, by way of a placing of 40,000,000 new ordinary shares (the "Placing Shares") (the "Placing") and a subscription for 160,000,000 new ordinary shares (the "Subscription Shares") (the "Subscription") at a price of 0.25 pence per share (the "Issue Price"). The Placing and the Subscription together constitute the "Fundraise".

The Issue Price represents a discount of approximately 16% to the closing bid market price of the Company's ordinary shares on AIM of 0.30 pence on 24 September 2020, being the latest practicable date prior to this announcement. The Placing Shares and Subscription Shares (together, the "Fundraise Shares") represent approximately 35% of the Company's issued share capital as enlarged by the Fundraise.

Participants in the Fundraise will be issued with one warrant for every Fundraise Share subscribed for (the "Fundraise Warrants"), resulting in the issue of 200,000,000 Fundraise Warrants, as well as 12,000,000 warrants to an arranger of the Fundraise ("Arrangement Warrants"). The Fundraise Warrants and the Arrangement Warrants will be exercisable for a period of two years at a price of 0.35 pence per share, which equates to a premium of 40% to the Issue Price.

The Company does not currently have the requisite share authorities to issue new ordinary shares in connection with the potential future exercise of all of the warrants issued in connection with the Fundraise. Therefore, their issue is conditional on shareholder approval at a duly convened general meeting. Further announcements in this regard will be made in due course.

Admission and Total Voting Rights

The Fundraise is conditional only on the admission of the Fundraise Shares to trading on AIM ("Admission"). Application will be made for Admission of the 200,000,000 Fundraise Shares which is expected to occur at 8.00 a.m. on or around 8 October 2020.

Following Admission, the Company will have 579,520,534 ordinary shares in issue, none of which will be held in treasury. Accordingly, the total number of voting rights in the Company will be 579,520,534 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 

 

Matt Lofgran, Nostra Terra 's Chief Executive Officer, said:

"We've previously stated that we're focused on increasing our cashflow in the near-term, through acquisition and development of producing assets or those that can be put into production quickly, all with long-life reserves and additional upside opportunity.

 

We now have three distinct areas of operations further balancing our portfolio, with activity in each area aimed towards increasing production and reserves in the near-term. Those activities are now funded through investment from new and existing institutional and professional investors. We look forward to updating on all fronts as progress continues."

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 

For further information, contact:

 

Nostra Terra Oil and Gas Company plc

Matt Lofgran, CEO

 

Email:

+1 480 993 8933

Strand Hanson Limited

(Nominated & Financial Adviser and Joint Broker)

Rory Murphy / Ritchie Balmer / Jack Botros

 

Tel:

+44 (0) 20 7409 3494

Novum Securities Limited (Joint Broker)

Jon Belliss

 

Lionsgate Communications (Public Relations)

Jonathan Charles

Tel:

 

 

Tel:

+44 (0) 207 399 9425

 

 

+44 (0) 7791 892509

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESEIFFIESSESU
Date   Source Headline
26th Jun 20257:00 amRNSChange of Name
20th Jun 202510:40 amRNSResults of Annual General Meeting
3rd Jun 20257:00 amRNS-REngage Investor Presentation
23rd May 20257:00 amRNS2024 Audited Annual Results & Notice of AGM
3rd Apr 20257:00 amRNSPartner Approval for Fouke 3 Well
17th Mar 20257:00 amRNS-REngage Investor Presentation
11th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20257:00 amRNSCompletion of £500,000 Fundraise
24th Feb 20257:00 amRNSProduction and Operations Update
11th Feb 202512:57 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNS3-Year Renewal of Senior Lending Facility
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 202512:29 pmRNSHolding(s) in Company
21st Jan 20257:05 amRNSIncreased Holdings in the Company
21st Jan 20257:00 amRNSProduction and Operations Update
2nd Jan 20257:00 amRNSBoard Change
27th Dec 20244:35 pmRNSHolding(s) in Company
27th Dec 20247:00 amRNSHolding(s) in Company
28th Nov 202412:15 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSFundraise to increase production & cash flow
12th Nov 20244:48 pmRNSHolding(s) in Company
11th Nov 20247:00 amRNSProduction and Operations Update
20th Sep 202411:50 amRNSShare Issuance
20th Sep 20247:00 amRNSShare Issuance
19th Sep 20247:00 amRNSInterim Results for six months ended 30 June 2024
6th Sep 20247:00 amRNSChange of Nominated Adviser
29th Aug 202412:30 pmRNSHolding(s) in Company
27th Aug 202412:41 pmRNSHolding(s) in Company
22nd Aug 20244:54 pmRNSHolding(s) in Company
20th Aug 202412:15 pmRNSHolding(s) in Company
19th Aug 20243:52 pmRNSHolding(s) in Company
16th Aug 20244:45 pmRNSHolding(s) in Company
16th Aug 20247:00 amRNSHolding(s) in Company
14th Aug 20244:56 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSHolding(s) in Company
7th Aug 202411:52 amRNSHolding(s) in Company
2nd Aug 20244:28 pmRNSDirector Increases Participation in Fundraise
29th Jul 20247:00 amRNS£450,000 Fundraise aimed at increasing production
17th Jul 202411:08 amRNSAdvisor Change
17th Jul 202410:13 amRNSResult of Meeting
1st Jul 20245:00 pmRNSCorporate Update & Notice of General Meeting
27th Jun 20242:46 pmRNSResult of AGM
27th Jun 20247:00 amRNSAppointment of Non-Executive Director
13th Jun 20247:00 amRNSProposed Appointment of Non-Executive Director
31st May 20247:00 amRNSFinal Results
20th May 20248:01 amRNSBoard Changes
22nd Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20249:23 amRNSHolding(s) in Company
30th Jan 20249:37 amRNSHolding(s) in Company
30th Jan 20249:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.